PharmaShots

FEBRUARY 22, 2023

In the US, Trulicity is protected by a compound patent (2027) and by biologics data protection (2026).

Insurance 64

Insurance Compounding Dosage Communication 64

Pharmaceutical Technology

JUNE 21, 2023

Dr. Doug Cole, co-founder of Empress Therapeutics, explained that Chemilogics links gene pathways to small molecule compounds, allowing for drugs with the versatility of small molecules without the unpredictable, expensive, and time-consuming discovery process. Murray KcKinnon, PhD He joined Empress as chief scientific officer.

Compounding 52

Compounding Communication Immunization 52

Pharmacy Times

JULY 7, 2025

Takeda will discontinue Gammagard S/D by December 2027, transitioning to the new low IgA formulation. Takeda has informed the FDA that the manufacturing of Gammagard S/D will cease in December 2027.

FDA 97

FDA Immunization Compounding Pharmacies Hospitals 97

Pharmaceutical Technology

APRIL 24, 2023

Meanwhile, the Indian biologics market is expected to grow to $12 billion by 2025, with a compound annual growth rate (CAGR) of 22%. GlobalData forecasts Biologics to significantly overtake sales of small molecules by $120 billion by 2027. Please check your email to download the Whitepaper.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Compounding 52

ISPE

SEPTEMBER 11, 2023

Examples include platforms as small as autonomous units placed within a facility and mobile production trailers for compounding to platforms as large as a prefabricated, self-contained GMP facility. Nature Communications 12, no. 3 , 27 Advantages POD increases manufacturing flexibility, speed, and consistency. 3 (2020):e2970.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Documentation Packaging 52

ISPE

MARCH 8, 2023

5 , 8 Compounding pharmacies were commonly mentioned as sources of microbial cross-contamination, especially in the US. 9 , 15 This has led to compounding pharmacies completing high-volume activities such as mass repackaging, thereby increasing the risk of cross-contamination. Compounding Pharmacies: Who Is in Charge?”

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52